24-norursodeoxycholic acid has been researched along with Inflammation in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, HX; Liang, ZY; Qin, SY; Su, SB; Wang, F; Yan, YD; Zhangdi, HJ | 1 |
| Alteneder, M; Baazim, H; Bergthaler, A; Boucheron, N; Claudel, T; Donner, C; Ellmeier, W; Fuchs, CD; Gülich, AF; Hainberger, D; Halilbasic, E; Hamminger, P; Khan, M; Lercher, A; Májek, P; Müller, AC; Ohradanova-Repic, A; Preglej, T; Remetic, J; Sakaguchi, S; Sandner, L; Scharnagl, H; Schatzlmaier, P; Stockinger, H; Stojakovic, T; Trauner, M; Viczenczova, C; Weichhart, T; Zhu, C | 1 |
| Claudel, T; Engelmann, R; Fickert, P; Fuchs, CD; Guenther, ND; Langner, C; Loebermann, M; Mueller, M; Mueller-Hilke, B; Österreicher, CH; Reisinger, EC; Sahin, E; Schramm, C; Schwinge, D; Sombetzki, M; Trauner, M | 1 |
1 review(s) available for 24-norursodeoxycholic acid and Inflammation
| Article | Year |
|---|---|
Crosstalk network among multiple inflammatory mediators in liver fibrosis.
Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Disease Models, Animal; Hepatic Stellate Cells; Hepatocytes; Humans; Imidazoles; Inflammation; Inflammation Mediators; Liver; Liver Cirrhosis; Molecular Targeted Therapy; Protein Kinase Inhibitors; Pyrimidinones; Signal Transduction; Sulfoxides; Ursodeoxycholic Acid | 2019 |
2 other study(ies) available for 24-norursodeoxycholic acid and Inflammation
| Article | Year |
|---|---|
24-Norursodeoxycholic acid reshapes immunometabolism in CD8
Topics: Animals; CD8-Positive T-Lymphocytes; Disease Models, Animal; Inflammation; Liver; Mice; Mice, Inbred C57BL; Ursodeoxycholic Acid | 2021 |
24-nor-ursodeoxycholic acid ameliorates inflammatory response and liver fibrosis in a murine model of hepatic schistosomiasis.
Topics: Animals; Cholagogues and Choleretics; Disease Models, Animal; Drug Monitoring; Granuloma; Immunohistochemistry; Inflammation; Liver Cirrhosis; Lymphocyte Activation; Mice; Schistosomiasis mansoni; T-Lymphocytes; Treatment Outcome; Ursodeoxycholic Acid | 2015 |